Chemoinformaics analysis of 3-HYDROXY-5-PHENYLVALERIC ACID
| Molecular Weight | 194.23 | nRot | 5 |
| Heavy Atom Molecular Weight | 180.118 | nRig | 7 |
| Exact Molecular Weight | 194.094 | nRing | 1 |
| Solubility: LogS | -1.326 | nHRing | 0 |
| Solubility: LogP | 1.446 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 30.1111 |
| nHD | 2 | BPOL | 14.9129 |
| QED | 0.746 |
| Synth | 2.098 |
| Natural Product Likeliness | 0.86 |
| NR-PPAR-gamma | 0.924 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.022 |
| HIA | 0.453 |
| CACO-2 | -5.118 |
| MDCK | 0.0000211 |
| BBB | 0.356 |
| PPB | 0.695091 |
| VDSS | 0.14 |
| FU | 0.2487 |
| CYP1A2-inh | 0.038 |
| CYP1A2-sub | 0.076 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.316 |
| CYP2c9-inh | 0.01 |
| CYP2c9-sub | 0.927 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.243 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.137 |
| CL | 10.832 |
| T12 | 0.864 |
| hERG | 0.029 |
| Ames | 0.015 |
| ROA | 0.017 |
| SkinSen | 0.302 |
| Carcinogencity | 0.08 |
| EI | 0.965 |
| Respiratory | 0.049 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.746942 |